ARNA
Arena Pharmaceuticals Inc
Price:  
99.99 
USD
Volume:  
5,621,235.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ARNA EV/EBITDA

-254.6%
Upside

As of 2024-05-20, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.8x - 19.9x 15.9x
Forward P/E multiples 17.6x - 21.8x 19.8x
Fair Price (152.78) - (173.29) (154.59)
Upside -252.8% - -273.3% -254.6%
99.99 USD
Stock Price
(154.59) USD
Fair Price

ARNA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA